Name: Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine (en Inglés)
Price: 204.59 USD
Availability: InStock
Author: Behl, Tapan; Srivastav, Shriyansh; Singh, Sukhbir
ISBN: 9780443315923

portada Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine (en Inglés)

Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Behl, Tapan; Srivastav, Shriyansh; Singh, Sukhbir

Idioma

Inglés

N° páginas

380

Encuadernación

Tapa Blanda

ISBN13

9780443315923

Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine (en Inglés)

Behl, Tapan; Srivastav, Shriyansh; Singh, Sukhbir (Autor) · Academic Press · Tapa Blanda

Libro Nuevo Importado

Envío: 23 a 30 días háb.

$ 371.99$ 204.59

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 204.59

Llega entre el 07 Sep y el 18 Sep a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine (en Inglés)"

Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine gives readers a comprehensive and up-to-date resource on the latest developments and trends in the field of cancer pharmacology. It serves as a valuable reference for researchers, scientists, clinicians, and other professionals involved in cancer research, pharmacology, oncology, and personalized medicine. In recent years, there have been significant breakthroughs in understanding the molecular mechanisms of cancer and the development of targeted therapies. Additionally, personalized medicine has emerged as a promising approach to tailor treatments based on an individual's genetic profile, tumor characteristics, and other factors. These developments have the potential to revolutionize cancer treatment and improve patient outcomes. This book covers such developments.